glp-1 nejm Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential Semaglutide and Cardiovascular Outcomes in

Understanding the distinction between common, expected adverse effects and unproven long-term concerns helps contextualize patient experiences and clinical decision-making

But now another potential side effect has been thrown into the spotlight, literally, by global superstar Robbie Williams

Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis

20.12 Congenital Melanocytic Nevus 20.12.1 Clinical Features Congenital melanocytic nevi are melanocytic lesions that appear as pink/tan/brown to black macules and patches or papules and plaques (Figs

Glutathione is not an overnight solution, but with proper guidance and consistency, it delivers gradual and natural-looking improvements

A stall at month 10 on semaglutide is not failure